These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6731499)

  • 1. Use of noninvasive laboratory testing in the prediction of thrombosis in the nephrotic syndrome.
    Francis RB; Sandler RM; Levitan D; Weiner J; Feinstein EI; Massry SG; Feinstein DI
    Am J Nephrol; 1984; 4(1):43-7. PubMed ID: 6731499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
    Francis RB; Sandler RM; Levitan D; Feinstein EI; Massry SG; Feinstein DI
    Nephron; 1985; 39(4):325-9. PubMed ID: 3157072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood viscosity and haemostasis in the nephrotic syndrome.
    McGinley E; Lowe GD; Boulton-Jones M; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Jun; 49(3):155-7. PubMed ID: 6410531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombosis in various diseases: kidney diseases and blood coagulation].
    Narita M
    Nihon Rinsho; 1986 May; 44(5):1104-9. PubMed ID: 3528570
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria.
    Lau SO; Tkachuck JY; Hasegawa DK; Edson JR
    J Pediatr; 1980 Mar; 96(3 Pt 1):390-2. PubMed ID: 7359230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors, atherosclerosis and thromboembolism in the nephrotic syndrome].
    Previato G; Loschiavo C; Tessitore N; Chiaramonte S; Oldrizzi L; Lupo A; Valvo E; Maschio G; Saporiti E
    Minerva Nefrol; 1981; 28(3):421-30. PubMed ID: 7036020
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive study of haemostasis in nephrotic syndrome.
    Panicucci F; Sagripanti A; Vispi M; Pinori E; Lecchini L; Barsotti G; Giovannetti S
    Nephron; 1983; 33(1):9-13. PubMed ID: 6403881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):653-8. PubMed ID: 1836241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Features of thrombophilia in nephrotic syndrome in children].
    Serebrianyĭ VL; Ignatova MS; Degtiareva EM; Svetlov SI
    Pediatriia; 1989; (1):49-53. PubMed ID: 2710603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
    Rodzynek JJ; Urbain D; Leautaud P; Wettendorff P; Delcourt A
    Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of renal vein thrombosis in patients with nephrotic syndrome: a prospective study].
    Cheng H
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):416-9, 447. PubMed ID: 1330232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.
    Llach F
    Kidney Int; 1985 Sep; 28(3):429-39. PubMed ID: 3906225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary nephrotic syndrome treated with urokinase--a report of 20 cases].
    Wang LS; Chen EH; Zhou XJ
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):356-9, 382. PubMed ID: 2582915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome.
    Storti S; Pagano L; Marra R; Grilli A; Falappa G; De Gaetano AM; Ferrante AM; Bizzi B
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):743-5. PubMed ID: 2133253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral arterial thrombosis due to the nephrotic syndrome: the clinical spectrum.
    Sullivan MJ; Hough DR; Agodoa LC
    South Med J; 1983 Aug; 76(8):1011-6. PubMed ID: 6410516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorders of thrombin interaction with the blood vessel wall and its inactivation by antithrombin III in experimental nephrotic syndrome].
    Bashkov GV
    Biull Eksp Biol Med; 1990 Aug; 110(8):133-6. PubMed ID: 2291954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.